Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-01-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1337712/full |
| _version_ | 1827389534549049344 |
|---|---|
| author | Hassan Alwafi Hassan Alwafi Ian C. K. Wong Ian C. K. Wong Ian C. K. Wong Ian C. K. Wong Ian C. K. Wong Abdallah Y. Naser Amitava Banerjee Amitava Banerjee Amitava Banerjee Pajaree Mongkhon Pajaree Mongkhon Cate Whittlesea Alaa Alsharif Li Wei Li Wei Li Wei |
| author_facet | Hassan Alwafi Hassan Alwafi Ian C. K. Wong Ian C. K. Wong Ian C. K. Wong Ian C. K. Wong Ian C. K. Wong Abdallah Y. Naser Amitava Banerjee Amitava Banerjee Amitava Banerjee Pajaree Mongkhon Pajaree Mongkhon Cate Whittlesea Alaa Alsharif Li Wei Li Wei Li Wei |
| author_sort | Hassan Alwafi |
| collection | DOAJ |
| first_indexed | 2024-03-08T16:38:13Z |
| format | Article |
| id | doaj.art-625c7168c99c4d479171eb96cb8985ee |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-03-08T16:38:13Z |
| publishDate | 2024-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-625c7168c99c4d479171eb96cb8985ee2024-01-05T11:35:08ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2024-01-011010.3389/fmed.2023.13377121337712Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort studyHassan Alwafi0Hassan Alwafi1Ian C. K. Wong2Ian C. K. Wong3Ian C. K. Wong4Ian C. K. Wong5Ian C. K. Wong6Abdallah Y. Naser7Amitava Banerjee8Amitava Banerjee9Amitava Banerjee10Pajaree Mongkhon11Pajaree Mongkhon12Cate Whittlesea13Alaa Alsharif14Li Wei15Li Wei16Li Wei17Research Department of Practice and Policy, School of Pharmacy, University College London, London, United KingdomFaculty of Medicine, Umm Al Qura University, Mecca, Saudi ArabiaResearch Department of Practice and Policy, School of Pharmacy, University College London, London, United KingdomCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, ChinaDepartment of Pharmacy, The University of Hong Kong - Shenzhen Hospital, Shenzhen, ChinaLaboratory of Data Discovery for Health, Hong Kong Science Park, Pak Shek Kok, Hong Kong SAR, ChinaCentre for Medicines Optimisation Research and Education, University College London Hospitals National Health Service (NHS) Foundation Trust, London, United KingdomDepartment of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman, JordanInstitute of Health Informatics, University College London, London, United KingdomDepartment of Cardiology, University College London Hospitals NHS Trust, London, United Kingdom0Department of Cardiology, Barts Health NHS Trust, London, United Kingdom1Department of Pharmacy Practice, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand2Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University, Chiang Mai, ThailandResearch Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom3Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi ArabiaResearch Department of Practice and Policy, School of Pharmacy, University College London, London, United KingdomLaboratory of Data Discovery for Health, Hong Kong Science Park, Pak Shek Kok, Hong Kong SAR, ChinaCentre for Medicines Optimisation Research and Education, University College London Hospitals National Health Service (NHS) Foundation Trust, London, United Kingdomhttps://www.frontiersin.org/articles/10.3389/fmed.2023.1337712/fulloral anticoagulantshypoglycemiasulfonylureasdiabetes mellitusUnited Kingdomdrug-drug interactions |
| spellingShingle | Hassan Alwafi Hassan Alwafi Ian C. K. Wong Ian C. K. Wong Ian C. K. Wong Ian C. K. Wong Ian C. K. Wong Abdallah Y. Naser Amitava Banerjee Amitava Banerjee Amitava Banerjee Pajaree Mongkhon Pajaree Mongkhon Cate Whittlesea Alaa Alsharif Li Wei Li Wei Li Wei Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study Frontiers in Medicine oral anticoagulants hypoglycemia sulfonylureas diabetes mellitus United Kingdom drug-drug interactions |
| title | Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study |
| title_full | Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study |
| title_fullStr | Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study |
| title_full_unstemmed | Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study |
| title_short | Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study |
| title_sort | corrigendum concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia a uk population based cohort study |
| topic | oral anticoagulants hypoglycemia sulfonylureas diabetes mellitus United Kingdom drug-drug interactions |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2023.1337712/full |
| work_keys_str_mv | AT hassanalwafi corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT hassanalwafi corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT ianckwong corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT ianckwong corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT ianckwong corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT ianckwong corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT ianckwong corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT abdallahynaser corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT amitavabanerjee corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT amitavabanerjee corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT amitavabanerjee corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT pajareemongkhon corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT pajareemongkhon corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT catewhittlesea corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT alaaalsharif corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT liwei corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT liwei corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy AT liwei corrigendumconcurrentuseoforalanticoagulantsandsulfonylureasinindividualswithtype2diabetesandriskofhypoglycemiaaukpopulationbasedcohortstudy |